Cell Biotech Co. Ltd (049960) — Working Capital to Net Assets Ratio
Cell Biotech Co. Ltd (049960) has a Working Capital to Net Assets ratio of 73.7% as of September 2025. Working capital of ₩93.72 Billion (current assets of ₩101.09 Billion minus current liabilities of ₩7.37 Billion) is measured against net assets of ₩127.11 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See net asset quality index of Cell Biotech Co. Ltd to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Cell Biotech Co. Ltd Working Capital to Net Assets (2012–2024)
This chart shows how Cell Biotech Co. Ltd's Working Capital to Net Assets ratio has evolved across 13 annual periods from 2012 to 2024. As of September 2025, the ratio stands at 73.7%, reflecting working capital of ₩93.72 Billion against net assets of ₩127.11 Billion KRW. Check 049960 tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Cell Biotech Co. Ltd (2012–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Cell Biotech Co. Ltd from 2012 to 2024, covering 13 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see 049960 market cap.
| Year | WC/NA Ratio | Working Capital (KRW) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 73.5% | ₩91.29 Billion | ₩124.17 Billion | ₩97.15 Billion | ₩5.86 Billion | ▲ +4.6 pp |
| 2023 | 68.9% | ₩77.11 Billion | ₩111.89 Billion | ₩81.93 Billion | ₩4.82 Billion | ▲ +5.8 pp |
| 2022 | 63.2% | ₩68.27 Billion | ₩108.09 Billion | ₩75.66 Billion | ₩7.39 Billion | ▲ +5.3 pp |
| 2021 | 57.9% | ₩61.75 Billion | ₩106.69 Billion | ₩67.52 Billion | ₩5.77 Billion | ▼ -2.4 pp |
| 2020 | 60.3% | ₩60.28 Billion | ₩99.98 Billion | ₩64.91 Billion | ₩4.63 Billion | ▼ -2.5 pp |
| 2019 | 62.8% | ₩65.07 Billion | ₩103.60 Billion | ₩69.26 Billion | ₩4.19 Billion | ▼ -7.9 pp |
| 2018 | 70.7% | ₩74.65 Billion | ₩105.62 Billion | ₩81.05 Billion | ₩6.40 Billion | ▼ -1.0 pp |
| 2017 | 71.6% | ₩64.61 Billion | ₩90.20 Billion | ₩70.87 Billion | ₩6.26 Billion | ▼ -3.1 pp |
| 2016 | 74.8% | ₩62.91 Billion | ₩84.15 Billion | ₩69.27 Billion | ₩6.36 Billion | ▲ +5.0 pp |
| 2015 | 69.8% | ₩47.99 Billion | ₩68.76 Billion | ₩54.15 Billion | ₩6.16 Billion | ▲ +5.6 pp |
| 2014 | 64.2% | ₩33.59 Billion | ₩52.36 Billion | ₩38.80 Billion | ₩5.21 Billion | ▲ +6.7 pp |
| 2013 | 57.4% | ₩24.73 Billion | ₩43.05 Billion | ₩28.34 Billion | ₩3.61 Billion | ▼ -5.3 pp |
| 2012 | 62.7% | ₩22.84 Billion | ₩36.42 Billion | ₩26.73 Billion | ₩3.88 Billion | — |